Moderna’s mRNA RSV vaccine wins expanded FDA approval for younger adults
The label expansion for Moderna’s jab arrives at a juncture in America’s changing vaccine regulatory landscape.
The label expansion for Moderna’s jab arrives at a juncture in America’s changing vaccine regulatory landscape.
What's Your Reaction?
